IDEXX Laboratories IDXX

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    IDEXX Laboratories (IDXX) Business Model and Operations Summary
    IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

    Key Insights

    IDEXX Laboratories (IDXX) Core Market Data and Business Metrics
    • Latest Closing Price

      $647.09
    • Market Cap

      $42.45 Billion
    • Average Daily Volume

      792,593 Shares
    • 52-Week Range

      $356.14-$533.32
    • Price-Earnings Ratio

      59.80
    • Total Outstanding Shares

      80.00 Million Shares
    • CEO

      Jonathan J. Mazelsky
    • Total Employees

      11,000
    • Current Dividend

      No dividend
    • IPO Date

      June 21, 1991
    • SIC Description

      In Vitro & In Vivo Diagnostic Substances
    • Headquarters

      One Idexx Drive, Westbrook, ME, 04092-2041

    Earnings Reports

    Expected vs. Actual Quarterly Earnings-Per-Share & Revenue

    Short Volume

    Daily short volume activity identifies short-term trading pressure and potential price volatility

    Short Interest

    Bi-monthly short interest levels can be used to gauge bearish market sentiment and short squeeze potential

    Revenue Breakdown

    Distribution of revenue across unique business segments & geographies

    Cash Flow Statement

    April 1, 2024 to March 31, 2025

    Income Statement

    April 1, 2024 to March 31, 2025

    Comprehensive Income

    April 1, 2024 to March 31, 2025

    Balance Sheet

    April 1, 2024 to March 31, 2025

    Historical Stock Splits

    If you bought 1 share of IDXX before November 27, 2007, you'd have 4 shares today

    Historical Dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about IDXX from trusted financial sources

    Related Companies

    Publicly traded companies similar to IDEXX Laboratories (IDXX)
    Boost your savings and earn 3.95% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.